Mesoblast (MESO) EBT Margin (2016 - 2023)
Mesoblast recorded quarterly EBT Margin of 409.53% in Q2 2023, up 142.59% quarter-over-quarter from 961.63% in Q1 2023, and up 137657.0% year-over-year from N/an in Q2 2022.
Mesoblast's EBT Margin history runs 8 years deep, the most recent figure standing at 409.53% for Q2 2023.
- In Q2 2023, EBT Margin rose 137657.0% year-over-year to 409.53%; the TTM figure through Mar 2023 stood at 1076.31% (down 2985.0% YoY), while the FY2025 annual figure was 592.0%, changed N/A from the prior year.
- EBT Margin came in at 409.53% for Q2 2023 at Mesoblast, up from 961.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 409.53% in Q2 2023 to a low of 2607.97% in Q1 2019.
- A 5-year average of 1062.2% and a median of 1100.52% in 2021 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 178057 bps in 2020 and fell as far as 154055 bps in 2020.
- Mesoblast's EBT Margin stood at 1363.79% in 2019, then grew by 16 bps to 1143.15% in 2020, then increased by 4 bps to 1092.57% in 2021, then decreased by 14 bps to 1240.25% in 2022, then surged by 133 bps to 409.53% in 2023.
- According to Business Quant data, EBT Margin over the past three periods registered 409.53%, 961.63%, and 1240.25% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 409.53% |
| Mar 31, 2023 | -961.63% |
| Dec 31, 2022 | -1,240.25% |
| Sep 30, 2022 | -1,173.87% |
| Jun 30, 2022 | -967.04% |
| Mar 31, 2022 | -1,061.51% |
| Dec 31, 2021 | -1,092.57% |
| Sep 30, 2021 | -937.53% |
| Jun 30, 2021 | -1,108.47% |
| Mar 31, 2021 | -1,359.19% |
| Dec 31, 2020 | -1,143.15% |
| Sep 30, 2020 | -1,936.70% |
| Jun 30, 2020 | -136.72% |
| Mar 31, 2020 | -827.39% |
| Dec 31, 2019 | -1,363.79% |
| Sep 30, 2019 | -396.15% |
| Jun 30, 2019 | -1,215.20% |
| Mar 31, 2019 | -2,607.97% |
| Dec 31, 2018 | -2,257.11% |
| Sep 30, 2018 | -2,008.85% |
| Jun 30, 2018 | -1,285.59% |
| Mar 31, 2018 | -2,478.61% |
| Dec 31, 2017 | -163.37% |
| Sep 30, 2017 | -844.97% |
| Jun 30, 2017 | -5,522.61% |
| Mar 31, 2017 | -1,429.19% |
| Dec 31, 2016 | -5,352.66% |
| Sep 30, 2016 | -10,505.96% |
| Jun 30, 2016 | -127.29% |
| Mar 31, 2016 | -548.65% |